Forget the treat for cancer, heart disease, Alzheimer, or diabetes. Unless …
If you wish a cure for cancer, heart disease, Alzheimer, or diabetes, don’t count on the academia, the National Institute of Health (NIH), or the biotech/pharmaceutical industry. With all the money they need spent on researching these diseases, they need terribly little to point out for it.
In 1971, throughout the State of the Union address, President Nixon declared the war on cancer proposing “an intensive campaign to find a cure for cancer.” Since 1971, Americans spent, through taxes, donations, and personal R&D, about $200 billion in inflation-adjusted dollars. This cash made 1.fifty six million papers on cancer. Nonetheless, these days we tend to are not any nearer to a cure than we have a tendency to were in 1971. Why?
Consider what Dr. Almog said in his paper: Drug Business in “depression” (Almog, D. Drug industry in “depression”. Med Sci Monit. 2005 Jan;11(1):SR1-4, I might urge you to read his paper, it’s an eye opener on relationship between tutorial analysis and business drug discovery): “When the essential science/biology of disease isn’t out there, no new medication come to market.” With the billion of greenbacks spent by the NIH on basic science, and therefore the countless papers published on the topic, the query is, “Why isn’t the basic science/biology of disease obtainable? Individual discoveries within the biology of human disease are cornerstone in new treatments. However, in drug discovery, these basic science/biology discoveries are seemingly unrelated dots. To connect the dots you need a theory. The Blind Men and also the Elephant is a famous story concerning six blind men encountering an elephant for the primary time. Every man, seizing on the one feature of the animal, which he appeared to possess touched first, and being incapable of seeing it whole, loudly maintained his limited opinion on the nature of the beast. The elephant was thought-about a wall, a spear, a snake, a tree, a follower or a rope, depending on whether the blind men had 1st grasped the creature’s aspect, tusk, trunk, knee, ear or tail. The story epitomizes the problem of the reductionist approach in biology. A recent book Microcompetition with Foreign DNA and the Origin of Chronic Disease, by Hanan Polansky [11], presents an alternative. The book identifies the disruption that causes atherosclerosis, cancer, obesity, osteoarthritis, sort II diabetes, alopecia, type I diabetes, multiple sclerosis, asthma, lupus, thyroiditis, inflammatory bowel disease, rheumatoid arthritis, psoriasis, atopic dermatitis, graft versus host disease, and other chronic diseases, and describes the sequence of events that leads from the disruption to the molecular, cellular, and clinical effects.”
What are the implications of the NIH failure? A decline in the number of latest medication introduced by pharmaceutical companies. Take into account what professor Taylor says in his paper: Fewer new drugs from the pharmaceutical trade (Taylor D. Fewer new medication from the pharmaceutical industry. BMJ. 2003 Feb 22;326(7386):408-9): “In 2002 spending on medicines exceeded $400bn (£248bn; 377bn) worldwide. Optimists in the pharmaceutical business believe that the world marketplace for their product can persist expanding by around 10% a year, with the United States continuing to guide towards higher per capita outlays. Expenditure on research by the pharmaceutical business is also increasing worldwide. It is now over $45bn a year—twice the add recorded at the start of the 1990s—and projected to rise to $55bn by 2005-6. Concerns are growing, but, about the productivity of analysis being funded by the foremost pharmaceutical companies. … Empirical proof indicates a crisis in productivity in pharmaceutical research. The amount of medicines introduced worldwide that contain new active ingredients dropped from an average of over 60 a year in the late 1980s to 52 in 1991 and only 31 in 2001. The overall number of new active substances undergoing regulatory review remains falling.”
On the one hand, the expenditure on research is increasing. On the other, the quantity of new medicine is decreasing. The professionals call this case the productivity crisis in drug discovery.
The NIH failed to supply the thus much needed biology of chronic disease because it’s caught within the reductionist mentality. Dr. Hanan Polansky offers an alternative. If we want a cure for cancer, heart disease, Alzheimer, or diabetes, we have a tendency to would like to significantly take into account his alternative.
Posted in diabetes information | No Comments »
Bailey’s life with type-1 diabetes
Dr. Steven Knope, author of the new book Concierge Medicine, discusses Type 2 Diabete and how it can be cured through exercise and nutrition.
Be My Friend – http://www.myspace.com/psychtruth
http://tinyurl.com/5p6zwk